Gestational diabetes mellitus (GDM) poses significant risks to both mother and child, necessitating a comprehensive management approach. This article aims to elucidate such an approach to optimize patient outcomes.
Early detection and diagnosis are paramount in managing GDM. Universal screening between 24-28 weeks of gestation using an oral glucose tolerance test is recommended. Additionally, high-risk individuals should be screened at the first prenatal visit.
Medical nutrition therapy (MNT) is the cornerstone of GDM management. It involves individualized meal planning to achieve euglycemia, adequate nutrition, and appropriate weight gain. Regular dietetic consultations are essential to monitor progress and adjust the plan as necessary.
Physical activity complements MNT in achieving glycemic control. Unless contraindicated, pregnant women should aim for at least 150 minutes of moderate-intensity aerobic activity weekly, distributed over at least three days.
If MNT and physical activity fail to achieve glycemic targets within one to two weeks, pharmacological therapy should be initiated. Insulin is the first-line treatment, but oral hypoglycemic agents like metformin and glyburide are increasingly used.
Postpartum follow-up is crucial as GDM increases the risk of type 2 diabetes. A 75g oral glucose tolerance test should be performed at 6-12 weeks postpartum, followed by lifelong screening for diabetes at least every three years.
GDM management requires a comprehensive approach encompassing early detection, MNT, physical activity, pharmacological therapy, and postpartum follow-up. By adopting such a strategy, healthcare professionals can optimize outcomes for both mother and child, mitigating the risks associated with GDM.
1.
A Lot Can Be Said About You by Including Yourself in Photos.
2.
A new blood test greatly increases the ability to detect cancer.
3.
Novel biomarker has potential for predicting and treating skin cancer metastasis
4.
Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC
5.
No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer
1.
Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy
2.
Preventing Treatment-Related Secondary Malignancies: Evidence-Based Strategies for Clinical Practice
3.
Contemporary Frameworks in Oncology Across Clinical Settings
4.
What is Mullerian and How Does it Affect Your Health
5.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding Common Causes of Abnormal Blood Counts
2.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
3.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
4.
Understanding Cancer: Early Detection and Treatment
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation